Breast Cancer Research

official impact factor 5.79
Search for
Advanced search
Breast Cancer Research
Tools
Share this article
Open Access

Phase I dose escalation pharmacokinetic assessment of intravenous humanized anti-MUC1 antibody AS1402 in patients with advanced breast cancer

Mark D Pegram*, Virginia F Borges, Nuhad Ibrahim, Jyotsna Fuloria, Charles Shapiro, Susan Perez, Karen Wang, Franziska Schaedli Stark and Nigel Courtenay Luck

Breast Cancer Research 2009, 11:R73 doi:10.1186/bcr2409

Accesses  

  • Last 30 days: 57 accesses
  • Last 365 days: 629 accesses
  • All time: 2681 accesses

Cited by

Google Scholar: View citations

ISI Web of Science: View citations

PubMed Central: View citations